HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations

Brain Res Brain Res Rev. 2005 Dec 1;50(1):14-26. doi: 10.1016/j.brainresrev.2005.04.002.

Abstract

Oxidative stress is thought to play a role in the onset of dementia. HIV-dementia has recently been demonstrated to be associated with oxidative stress as indexed by increased protein and lipid peroxidation in the brain and cerebrospinal fluid compared to HIV non-demented patients. The HIV protein Tat induces neurotoxicity, and, more recently, Tat was found to induce oxidative stress directly and indirectly. The role of Tat in HIV-dementia and possible therapeutic strategies involving endogenous and exogenous antioxidants are discussed.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • AIDS Dementia Complex / drug therapy*
  • Animals
  • Antioxidants / therapeutic use*
  • Gene Products, tat / toxicity*
  • Humans
  • Models, Biological
  • Oxidative Stress / drug effects*
  • Oxidative Stress / physiology
  • tat Gene Products, Human Immunodeficiency Virus

Substances

  • Antioxidants
  • Gene Products, tat
  • tat Gene Products, Human Immunodeficiency Virus